Reports
Sale
Global Hodgkin’s Lymphoma Treatment Market Size, Forecast: By Treatment Type: Chemotherapy, Radiotherapy, Others; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Competitive Landscape; Key Trends and Developments in the Market; 2024-2032
Global Hodgkin’s Lymphoma Treatment Market Outlook
The global Hodgkin’s lymphoma treatment market reached a value of about USD 1.41 billion in 2023. The market is further estimated to grow at a CAGR of 13.20% in the forecast period of 2024-2032 to reach a value of around USD 4.31 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Radiotherapy to Propel the Market Growth of Hodgkin’s Lymphoma Treatment
Based on the treatment type, the radiotherapy segment holds significant market share of Hodgkin’s lymphoma treatment. The growing awareness about the effectiveness of radiotherapy in killing Hodgkin’s lymphoma cells is contributing to the steady market growth. Radiotherapy is painless, and the treatment is administered in short sessions that require no hospital stay, thereby accelerating the market development. In addition, radiotherapy can be given along with surgery, chemotherapy, hormones, or targeted therapy, which offers the patients with wide choices to treat the disease completely, thus bolstering the market. The availability of modern imaging tests that enables the doctors to aim at the lymphoma sites precisely can help limit side effects, which plays a critical role in expanding the market for Hodgkin’s lymphoma treatment. The rising inclination of healthcare professionals towards newer approaches to radiation, such as Involved site radiation therapy (ISRT), which reduces the size of the treatment area and helps spare nearby normal tissues from getting radiation, is leading to the market growth of Hodgkin’s lymphoma treatment.
Market Segmentation
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Hodgkin’s lymphoma is a type of cancer that spreads through the lymph vessels from lymph node to lymph node. The cancer in an advanced stage, though rarely, can invade the bloodstream and spread to other body parts, such as the liver, lungs, and bone marrow. There are two types of Hodgkin’s lymphoma - Classic Hodgkin lymphoma (cHL) and Nodular lymphocyte. The predominant treatments offered to cure the disease are chemotherapy, and radiotherapy, among others.
The market for Hodgkin’s lymphoma treatment, by treatment type, is divided into:
- Chemotherapy
- Radiotherapy
- Others
The regional markets for Hodgkin’s lymphoma treatment can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Worldwide Prevalence of Hodgkin’s Lymphoma to Drive the Market Growth of Hodgkin’s Lymphoma Treatment
The increasing prevalence of Hodgkin’s Lymphoma disease is leading to the market development of Hodgkin’s Lymphoma treatment. In 2019, about 218,740 people were living with Hodgkin lymphoma in the United States, and the region witnessed an estimated increase of 8,540 cases in 2023. The developing healthcare infrastructure and the rapid diagnosis of the disease are contributing to the market expansion of Hodgkin’s Lymphoma treatment. The growing awareness about the increased recovery chance of the disease among the people and the importance of treatments in it is further propelling the market for Hodgkin’s Lymphoma treatment. The government initiatives in approving novel drugs to treat Hodgkin’s Lymphoma play a critical role in expanding the market. In 2018, the U.S. FDA approved Adcetris (brentuximab vedotin) to treat adult patients with earlier untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with chemotherapy. The development of efficient therapies due to the research activities and the rising clinical trials is expected to augment the market for Hodgkin’s lymphoma treatment over the forecast period.
Key Players in the Global Hodgkin’s Lymphoma Treatment Market
The report gives a detailed analysis of the following key players in the global Hodgkin’s lymphoma treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Alkem Laboratories
- Amneal Pharmaceuticals, Inc.
- Baxter International Inc.
- Biogen Inc.
- Bristol-Myers Squibb Company
- F Hoffmann-La Roche Ltd
- Incyte Corp.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Hodgkin’s Lymphoma Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Hodgkin’s Lymphoma Treatment Historical Market (2018-2023)
8.3 Global Hodgkin’s Lymphoma Treatment Market Forecast (2024-2032)
8.4 Global Hodgkin’s Lymphoma Treatment Market by Treatment Type
8.4.1 Chemotherapy
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Radiotherapy
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Others
8.5 Global Hodgkin’s Lymphoma Treatment Market by Region
8.5.1 North America
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Europe
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Asia Pacific
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Latin America
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Middle East and Africa
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
9 North America Hodgkin’s Lymphoma Treatment Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Hodgkin’s Lymphoma Treatment Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Hodgkin’s Lymphoma Treatment Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Hodgkin’s Lymphoma Treatment Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Hodgkin’s Lymphoma Treatment Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Alkem Laboratories
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Amneal Pharmaceuticals, Inc.
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Baxter International Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Biogen Inc.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Bristol-Myers Squibb Company
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 F Hoffmann-La Roche Ltd
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Incyte Corp.
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 Others
16 Key Trends and Developments in the Market
List of Figures and Tables
1. Global Hodgkin’s Lymphoma Treatment Market: Key Industry Highlights, 2018 and 2032
2. Global Hodgkin’s Lymphoma Treatment Historical Market: Breakup by Treatment Type (USD Billion), 2018-2023
3. Global Hodgkin’s Lymphoma Treatment Market Forecast: Breakup by Treatment Type (USD Billion), 2024-2032
4. Global Hodgkin’s Lymphoma Treatment Historical Market: Breakup by Region (USD Billion), 2018-2023
5. Global Hodgkin’s Lymphoma Treatment Market Forecast: Breakup by Region (USD Billion), 2024-2032
6. North America Hodgkin’s Lymphoma Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
7. North America Hodgkin’s Lymphoma Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
8. Europe Hodgkin’s Lymphoma Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
9. Europe Hodgkin’s Lymphoma Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
10. Asia Pacific Hodgkin’s Lymphoma Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
11. Asia Pacific Hodgkin’s Lymphoma Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
12. Latin America Hodgkin’s Lymphoma Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
13. Latin America Hodgkin’s Lymphoma Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Middle East and Africa Hodgkin’s Lymphoma Treatment Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Middle East and Africa Hodgkin’s Lymphoma Treatment Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Global Hodgkin’s Lymphoma Treatment Market Structure
Key Questions Answered in the Report
In 2023, the global Hodgkin’s lymphoma treatment market attained a value of nearly USD 1.41 billion.
The market is assessed to grow at a CAGR of 13.20% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach almost USD 4.31 billion by 2032.
The major market drivers include the increased recovery chances through effective treatments, rapid diagnosis of the disease, developing healthcare infrastructure, and growing awareness about the different treatments available to cure the disease.
The key market trends include government initiatives in approving drugs, and research activities done to develop new therapies and drugs.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The various treatment types of Hodgkin’s lymphoma treatment, include chemotherapy, and radiotherapy, among others.
The major players in the market are Alkem Laboratories, Amneal Pharmaceuticals, Inc., Baxter International Inc., Biogen Inc., Bristol-Myers Squibb Company, F Hoffmann-La Roche Ltd, and Incyte Corp., among others.
Analyst Review
The global Hodgkin’s lymphoma treatment market attained a value of nearly USD 1.41 billion in 2023, driven by the prevalence of Hodgkin’s lymphoma and rising treatment development for increased recovery rate. Aided by the development of new drugs and therapies, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 13.20%. The market is estimated to reach about USD 4.31 billion by 2032.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The market for Hodgkin’s lymphoma treatment, by treatment type, is divided into chemotherapy, and radiotherapy, among others. The major regional markets for Hodgkin’s lymphoma treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Alkem Laboratories, Amneal Pharmaceuticals, Inc., Baxter International Inc., Biogen Inc., Bristol-Myers Squibb Company, F Hoffmann-La Roche Ltd, and Incyte Corp., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER